Restoridyn® (Tart Cherry Extract — Anthocyte)

Prunus cerasus
Evidence Level
Limited
3 Clinical Trials
6 Documented Benefits
2/5 Evidence Score

Restoridyn® is a branded tart cherry extract from Anthocyte Inc. sold for exercise recovery. Important caveat up front: none of the studies cited on this page actually tested Restoridyn®. They tested generic Montmorency tart cherry juice, concentrate, capsules or a citrate mixture, so the evidence here belongs to tart cherry in general, not to this brand. It is standardized for anthocyanin content, but no bioavailability or pharmacokinetic study of Restoridyn® appears among the references on this page. The closest supporting trial gave 20 physically active women, average age about 19, 30 ml of Montmorency tart cherry concentrate twice daily for 8 days. Jump performance recovered faster, while muscle soreness (p=0.070) and pain sensitivity (p=0.071) were only trends, and limb swelling and the inflammation marker hs-CRP did not change at all. A standardized extract may deliver more consistent anthocyanin content than juice, but that is a manufacturing claim, not a demonstrated health advantage. The honest framing: there is no head to head trial showing Restoridyn® works better than ordinary tart cherry juice or concentrate, and the trials that do exist are small and short. The sleep and uric acid research cited here used tart cherry juice and concentrate rather than this extract, and the sleep study had only 8 people who finished it.

Studied Dose The label dose is 480 mg once or twice daily. This is not the dose that was studied: the recovery trial used 30 ml of tart cherry concentrate twice daily for 8 days, and the sleep pilot used 240 ml of juice twice daily, so no cited study tested 480 mg of extract.
Active Compound Restoridyn® standardized tart cherry extract (Anthocyte Inc.), standardized for anthocyanins. Note that the cited studies used Montmorency tart cherry juice, concentrate, capsules or a citrate mixture rather than this branded extract, and those forms are not interchangeable.

Benefits

Faster jump recovery in one small trial of young women

In 20 physically active women aged around 19, Montmorency tart cherry concentrate (30 ml twice daily for 8 days) sped up recovery of countermovement jump height after muscle damaging exercise. Soreness and pain sensitivity did not reach statistical significance (p=0.070 and p=0.071), limb swelling did not change, and neither did the inflammation marker hs-CRP. The product tested was generic concentrate, not Restoridyn®, and the result has not been repeated in men, in older adults or in trained athletes.

Standardized anthocyanin delivery

A standardized extract is meant to deliver a consistent amount of anthocyanins from batch to batch, which juice does not guarantee. That is a quality claim about the raw material. No study on this page compares the standardized extract with juice for any health outcome, so consistency has not been shown to produce better results.

No published pharmacokinetic data behind this page

None of the four references on this page reports bioavailability or pharmacokinetic data for Restoridyn®, and none tests whether dose timing matters. Treat any timing protocol built on this ingredient as unproven.

Who was actually studied

The exercise study enrolled 20 recreationally active young women, not trained competitive athletes, and no cited trial used Restoridyn® itself. The other references were in adults over 50 with insomnia (8 people completed it), in 48 adults given a single dose, and in 282 men with diagnosed gout who were also starting a prescription urate lowering drug. Results from patients being treated for a disease do not tell you what this product does for a healthy person.

Sugar-free standardized format

An extract capsule avoids the sugar in tart cherry juice, which runs roughly 25 to 30 g per cup. That is a genuine practical difference if you are watching sugar intake. Bear in mind that the recovery, sleep and uric acid results on this page all came from juice or concentrate, sugar included, so the sugar free extract form has not itself been tested for those outcomes.

What the brand premium actually buys

Anthocyte markets this ingredient to sports nutrition brands with batch to batch consistency as the selling point. Nothing on this page tests whether that consistency changes how you feel or perform, so the higher price buys manufacturing control rather than proven extra benefit.

Mechanism of action

1

Anthocyanin-mediated anti-inflammatory effects

Tart cherry anthocyanins have been shown in laboratory work to dampen COX-1, COX-2 and prostaglandin activity. That is a test tube explanation, not a demonstrated effect in people. In the human studies cited here the inflammation marker hs-CRP did not change after tart cherry, either after damaging exercise or after a single dose, so the NSAID comparison is not supported by this page's own evidence.

2

Antioxidant activity in the lab, not confirmed in people

Anthocyanins can neutralize reactive oxygen species in laboratory conditions. This did not carry over to people in the study cited here: in 48 participants followed over 48 hours, antioxidant capacity (ORAC) did not change over time (p=0.42) and did not differ between groups (p=0.21). The antioxidant idea should be treated as unproven for this ingredient.

3

Blood levels have not been published

No measurements of blood anthocyanin levels after taking Restoridyn® are cited on this page, so reproducible plasma levels and downstream tissue effects are a manufacturer expectation rather than a documented finding.

Clinical trials

1
Tart cherry concentrate and jump recovery in 20 young women (2019)

Trial in 20 recreationally active young women, European Journal of Sport Science, 2019 (PMID 30058460).

Clinical population described in trial publication.

20 physically active women, average age about 19, took 30 ml of Montmorency tart cherry concentrate twice daily for 8 days. Countermovement jump height recovered significantly faster than in the comparison group. Muscle soreness (p=0.070) and pain pressure threshold (p=0.071) were trends only, and limb girth and hs-CRP showed no effect. The product tested was generic tart cherry concentrate, not Restoridyn®.

2
Single dose study: uric acid down, antioxidant capacity unchanged (2021)

Documented pharmacokinetic data supporting timing-specific protocols for athletic recovery.

Clinical population described in trial publication.

48 participants were followed for 48 hours after taking Montmorency tart cherry. Serum uric acid fell by about 8% (group by time p=0.02). Antioxidant capacity (ORAC) did not change over time (p=0.42) and did not differ between groups (p=0.21), and hs-CRP did not change either (p=0.64 over time, p=0.47 between groups).

3
Sleep pilot with 8 people who completed it (2018)

Quality control studies validate Restoridyn® batch-to-batch consistency in anthocyanin content and bioactive delivery.

Clinical population described in trial publication.

Eleven adults over 50 with insomnia were randomised and three were excluded, leaving 8 who finished. Drinking 240 ml of tart cherry juice twice daily increased measured sleep time by about 84 minutes on overnight sleep monitoring. Eight completers is far too few to rely on, the juice is not this branded extract, and sleep is not a use this page recommends.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated at typical doses.
Mild GI discomfort possible at higher doses in sensitive individuals.
The cited studies were small and short, up to 8 days in the exercise trial, so they cannot detect uncommon or delayed side effects.
No long term safety study of this extract is cited here. Tart cherry itself has a long history of use as a food.
If you are pregnant or breastfeeding, check with your healthcare provider before taking concentrated fruit extracts.

Important Drug interactions

Generally minimal drug interactions documented.
Theoretical caution with anticoagulants through possible mild antiplatelet effects of anthocyanins.
Interactions with common cardiovascular, metabolic or psychiatric medicines have not been formally studied, so absence of reports is not the same as absence of risk.
The gout study cited here gave a tart cherry citrate mixture to 282 men who were also starting the prescription drug febuxostat, so anyone taking urate lowering medicine should speak to their doctor before adding tart cherry products. The same applies if you regularly take NSAIDs.

Frequently asked questions about Restoridyn® (Tart Cherry Extract — Anthocyte)

What is Restoridyn?

Restoridyn® is a branded tart cherry extract from Anthocyte Inc. sold for exercise recovery. Important caveat up front: none of the studies cited on this page actually tested Restoridyn®.

What is Restoridyn used for?

Restoridyn is researched primarily for Athletic Performance and Muscle & Recovery. In 20 physically active women aged around 19, Montmorency tart cherry concentrate (30 ml twice daily for 8 days) sped up recovery of countermovement jump height after muscle damaging exercise.

What is the recommended dosage of Restoridyn?

The clinically studied dose is The label dose is 480 mg once or twice daily. This is not the dose that was studied: the recovery trial used 30 ml of tart cherry concentrate twice daily for 8 days, and the sleep pilot used 240 ml of juice twice daily, so no cited study tested 480 mg of extra… Always follow the product label and check with a healthcare provider for personal advice.

Is Restoridyn safe, and does it have side effects?

For most healthy adults, Restoridyn is well tolerated at studied doses. Reported effects can include: Generally well-tolerated at typical doses. Mild GI discomfort possible at higher doses in sensitive individuals. It may also interact with some medications. Restoridyn is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Restoridyn interact with any medications?

Possible interactions include: Generally minimal drug interactions documented. Theoretical caution with anticoagulants through possible mild antiplatelet effects of anthocyanins. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Restoridyn?

NutraSmarts rates the evidence for Restoridyn as Limited (2 out of 5). It is backed by 3 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Losso JN, Finley JW, Karki N, Liu AG, Prudente A, Tipton R, Yu Y, Greenway FL Pilot Study of the Tart Cherry Juice for the Treatment of Insomnia and Investigation of Mechanisms Am J Ther. 2018;25(2):e194-e201. doi: 10.1097/MJT.0000000000000584.PubMedUsed to support: Studied in adults over 50 with insomnia: 240 ml of tart cherry juice twice daily increased measured sleep time by about 84 minutes. This page makes no sleep claim, and the study does not support one. Honesty: very small pilot study (n=8 completers), generic tart cherry, not Restoridyn-specific.
  2. Brown MA, Stevenson EJ, Howatson G Montmorency tart cherry (Prunus cerasus L.) supplementation accelerates recovery from exercise-induced muscle damage in females Eur J Sport Sci. 2019;19(1):95-102. doi: 10.1080/17461391.2018.1502360.PubMedUsed to support: Supports the exercise-recovery claim: Montmorency tart cherry accelerated recovery of muscle function after exercise-induced damage in females. Honesty: only 20 physically active young women over 8 days, using generic Montmorency tart cherry concentrate rather than Restoridyn®. Jump recovery improved, but soreness (p=0.070) and pain pressure threshold (p=0.071) were trends only, and limb girth and hs-CRP did not change.
  3. Hillman AR, Uhranowsky K Acute Ingestion of Montmorency Tart Cherry Reduces Serum Uric Acid but Has no Impact on High Sensitivity C-Reactive Protein or Oxidative Capacity Plant Foods Hum Nutr. 2021;76(1):83-89. doi: 10.1007/s11130-021-00879-7.PubMedUsed to support: Supports the uric-acid claim: acute Montmorency tart cherry lowered serum uric acid. Honesty: it did not change hs-CRP or oxidative capacity here, so the anti-inflammatory/antioxidant effect was null in this study; acute crossover in 48 people using generic tart cherry, not Restoridyn®. ORAC was p=0.42 over time and p=0.21 between groups; hs-CRP was p=0.64 and p=0.47.
  4. Wang C, Sun W, Dalbeth N, Wang Z, Wang X, Ji X, Xue X, Han L, Cui L, Li X, Liu Z, Ji A, He Y, Sun M, Li C Efficacy and safety of tart cherry supplementary citrate mixture on gout patients: a prospective, randomized, controlled study Arthritis Res Ther. 2023;25(1):164. doi: 10.1186/s13075-023-03152-1.PubMedUsed to support: Supports the uric-acid/gout claim: adding a tart cherry preparation improved urate-related outcomes in gout patients versus control. Honesty: 282 men with diagnosed gout, all of them starting the prescription drug febuxostat, in an open-label study, with the tart cherry given as part of a citrate mixture. Nothing here can be credited to tart cherry on its own, and none of it describes what a healthy person should expect.